• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

厦门市晚发现HIV/AIDS患者抗病毒治疗免疫重建情况及影响因素分析

通讯作者: 柯然, keranran@163.com
DOI:10.12201/bmr.202610.00049
声明:预印本系统所发表的论文仅用于最新科研成果的交流与共享,未经同行评议,因此不建议直接应用于指导临床实践。

Analysis of Immune Reconstitution and Its Influencing Factors in Late-Presenting HIV/AIDS Patients Receiving Antiretroviral Therapy in Xiamen City

Corresponding author: KE Ran, keranran@163.com
  • 摘要:摘要 目的 分析厦门市晚发现HIV/AIDS患者长期接受ART后免疫重建的状况及其影响因素。方法 采用回顾性队列研究。资料来源于“艾滋病综合防治信息系统”,研究对象为2006年1月至2025年12月期间确诊、现住址在厦门市、符合晚发现标准且规律随访≥4年的HIV/AIDS患者,共1642例。以最近一次随访CD4+T细胞计数判定免疫重建结局:≥350个/μL为良好,<350个/μL为不全。组间比较采用χ²检验或Mann-Whitney U检验;二元Logistic回归(Enter法)用于影响因素分析。结果 免疫重建不全413例(25.15%),良好1229例(74.85%)。初始CD4+T细胞计数较高是保护因素(OR=0.993, 95%CI: 0.991~0.994, P<0.001)。年龄≥50岁(相较于15~24岁,OR=2.205, 95%CI: 1.361~3.572, P=0.001)与曾发生失访或停药(OR=1.578, 95%CI: 1.234~2.017, P<0.001)则为独立危险因素;婚姻状况与感染途径未见独立影响。限定于病毒学抑制者(n=1493)重新分析,初始CD4+T细胞计数与年龄的关联基本不变,失访或停药的关联则减弱,未再有统计学意义(OR=1.217, 95%CI: 0.935~1.584)。结论 该人群免疫重建不全的比例较高,其发生与初始CD4水平、年龄及治疗连续性独立相关;失访或停药的不利影响,可能部分是通过病毒学失败实现的。应推进早发现、早治疗,并加强对老年及治疗中断风险患者的随访管理。关键词 艾滋病;免疫重建;晚发现;影响因素中图分类号 R512.91

    关键词: 艾滋病;免疫重建;晚发现;影响因素; ; ; 

     

    Abstract: Abstract Objective To analyze the status of immune reconstitution and its influencing factors in late-presenting HIV/AIDS patients in Xiamen City, Fujian Province, after receiving long-term ART. Methods This was a retrospective cohort study. Patients were identified from the “AIDS Comprehensive Prevention and Treatment Information System”. They were diagnosed between January 2006 and December 2025, had a current registered address in Xiamen City, met the criteria for late presentation, and had been receiving ART with regular follow-up for at least 4 years. A total of 1642 patients were included. Good immune reconstitution was defined as a CD4+T cell count ≥350 cells/μL at the most recent follow-up; incomplete reconstitution as a count <350 cells/μL. Inter-group comparisons used the chi-square test or the Mann-Whitney U test; influencing factors were analyzed with multivariate binary logistic regression (enter method). Results Among the 1642 late-presenting patients, 413 (25.15%) had incomplete immune reconstitution, and 1229 (74.85%) had good immune reconstitution. In univariate analysis, immune reconstitution was associated with age, marital status, transmission route, treatment interruption or loss to follow-up, initial CD4+T cell count, and initial viral load (all P<0.05). Multivariate logistic regression identified a higher initial CD4+T cell count as a protective factor against incomplete immune reconstitution (OR=0.993, 95%CI: 0.991~0.994, P<0.001). Age ≥50 years (versus 15-24 years, OR=2.205, 95%CI: 1.361~3.572, P=0.001) and any treatment interruption or loss to follow-up (OR=1.578, 95%CI: 1.234~2.017, P<0.001) were independent risk factors for incomplete immune reconstitution. Marital status and transmission route were not independently associated with incomplete immune reconstitution. In a sensitivity analysis restricted to virologically suppressed participants (most recent VL <50 copies/mL, n=1493), the associations with initial CD4+T cell count and age ≥50 years were essentially unchanged, whereas the association with treatment interruption or loss to follow-up was attenuated and no longer statistically significant (OR=1.217, 95%CI: 0.935~1.584). Conclusion The proportion of incomplete immune reconstitution is high among late-presenting HIV/AIDS patients in Xiamen City after long-term ART. A higher initial CD4 level was protective against incomplete immune reconstitution, whereas age ≥50 years and treatment interruption or loss to follow-up were independent risk factors for it. The adverse effect of the latter may be partly explained by virological failure. Early detection and treatment should be promoted, and follow-up management should focus on older patients and those at risk of treatment interruption.Key words AIDS; Immune Reconstitution; Late Presentation; Influencing Factors

    Key words: AIDS; Immune Reconstitution; Late Presentation; Influencing Factors

    提交时间:2026-10-22

    版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
  • 图表

  • 张娅玲, 张月华, 张莎, 劳云飞. 服药信念量表特异版在艾滋病抗病毒治疗患者中的适用性评价. 2024. doi: 10.12201/bmr.202407.00001

    周张青, 崔龚臻, 汪雪芬, 刘涧, 徐方燕, 李惠莉. 基于结构方程模型(SEM)分析艾滋病血液透析治疗患者抑郁影响因素. 2024. doi: 10.12201/bmr.202410.00037

    何玲雁, 师金川, 程江豪, 朱明利. 肝素结合蛋白、NLR、LMR及PLR在HIV/AIDS患者免疫功能重建评估中的应用价值. 2024. doi: 10.12201/bmr.202408.00040

    冯浩然, 梁笛. 抗艾滋病、结核病和疟疾全球基金与主要捐赠国的合作及其对中国的启示. 2022. doi: 10.12201/bmr.202210.00020

    李亚男, 沈玮, 王淑娜, 赵雪莹, 秦瑶, 李静, 晁晶晶. 伴幻听症状的精神分裂症患者积极应对现状及影响因素分析. 2025. doi: 10.12201/bmr.202501.00006

    孙福州, 王誉芳, 李志燕. 维持性血液透析患者血清钙磷与血红蛋白现状及影响因素分析. 2024. doi: 10.12201/bmr.202411.00029

    孙云凤, 战青, 王红荣, 丑苗苗, 郝佩雍, 李静怡. 老年人数字健康素养现状及影响因素分析——以甘肃省张掖市为例. 2026. doi: 10.12201/bmr.202601.00008

    周笑笑, 吴冬梅, 田玉龙, 段清源, 李敏杰. 瘢痕疙瘩术后放疗的疗效及影响因素分析. 2024. doi: 10.12201/bmr.202410.00014

    吕合凯, 邓姗姗, 范颜颜, 王辅之. 老年人数字健康技术应用障碍影响因素分析. 2023. doi: 10.12201/bmr.202311.00009

    王楠, 王国蓉, 施雯停, 李清炉. 维持性血液透析患者皮肤瘙痒影响因素的系统评价和Meta分析. 2024. doi: 10.12201/bmr.202410.00043

  • 序号 提交日期 编号 操作
    1 2026-06-05

    10.12201/bmr.202610.00049V1

    下载
  • 公开评论  匿名评论  仅发给作者

引用格式

邓晖文, 马桂林, 张建梅, 张婉君, 柯然. 厦门市晚发现HIV/AIDS患者抗病毒治疗免疫重建情况及影响因素分析. 2026. biomedRxiv.202610.00049

访问统计

  • 阅读量:21
  • 下载量: 0
  • 评论数:0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误